TJD-AD 2021-009 Disciplinary Decision - CrossFit

Previously the CrossFit Games Organisation, as non-signatory of the World Anti-Doping Code, imposed a 4 year period of ineligibility on the Brazilian Athlete after he tested positive for the prohibited substances Enobosarm (ostarine), LGD-4033 (ligandrol) and Metandienone. 

The sanction was imposed by CrossFit without a hearing although the Athlete wanted to be heard. In October 2020 the Brazilian Doping Control Authority (ABCD) confirmed in a Decision that the Athlete’s participation in competitions would be a violation of the Brazilian Anti-Doping Code. 

Hereafter in October 2020 the Athlete filed a request with the Brazilian Sports Justice Anti-Doping Tribunal (TJD-AD). The Athlete disputed the validity of the imposed CrossFit sanction and the ABCD Decision and requested to lift the imposed suspension. 

The TJD-AD Rapporteur established that under the Rules the anti-doping decision from CrossFit, as Non-Signatory, and the ABCD Decision are only valid after confirmation by the TJD-AD.

Due to the TJD-AD had not approved the CrossFit Decision the TJD-AD Rapporteur deemed that the ABCD Decision was invalid. 

Therefore the TJD-AD Panel decides on 5 April 2021 to lift the imposed sanction on the Athlete.

Original document

Parameters

Legal Source
National Decisions
Date
5 April 2021
Arbitrator
Nicolau, Jean Eduardo Batista
Rocha, Selma Fátima Melo
Sabioni, Paulo Rogério Oliveira
Original Source
Brazilian Sports Justice Anti-Doping Tribunal (TJD-AD)
Country
Brazil
Language
Portuguese
ADRV
Adverse Analytical Finding / presence
Legal Terms
Code compliance / code signatory
Competence / Jurisdiction
Procedural error
WADA Code, Guidelines, Protocols, Rules & Regulations
Worldwide adoption of sanction
Sport/IFs
CrossFit
Other organisations
Autoridade Brasileira de Controle de Dopagem (ABCD) - Brazilian Doping Control Authority
Tribunal de Justiça Desportiva Antidopagem (TJD-AD) - Brazilian Sports Justice Anti-Doping Tribunal
Doping classes
S1. Anabolic Agents
Substances
Enobosarm (ostarine)
LGD-4033 (ligandrol)
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Selective androgen receptor modulators (SARMs)
Document type
Pdf file
Date generated
22 September 2021
Date of last modification
11 January 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin